tirzepatide triple agonist Switching from to retatrutide: the complete transition guide Retatrutide: How the Triple Agonist

Novo Nordisk makes Wegovy while Mounjaro is made by Eli Lilly

This can make digestive side effects worse and lead to nausea and stomach discomfort, which can make it harder to tolerate the treatment and interfere with your weight loss journey

Clinical trials show that tirzepatide produces greater reductions in HbA1c and body weight than the best available GLP-1 receptor agonists

Avoiding high-fat foods decreases GI distress

Additionally, retatrutide markedly improved lipid profiles in people with T2D or obesity, reducing total cholesterol (~ 1518%), LDL (~ 1222%), and triglycerides (~ 3540%)surpassing dulaglutide 1.5 mg

Never needed the full 12mg dose to see results